The 130th Annual Meeting of APHA

3103.0: Monday, November 11, 2002 - 10:50 AM

Abstract #47721

Chlamydia and gonorrhea re-infection among young women in Philadelphia, PA

Nkiruka Ohameje1, Michael Eberhart, BS2, Lenore Asbel, MD2, and Martin Goldberg2. (1) MCP Hahnemann School of Public Health, Broad and Race Streets, Philadelphia, PA 19107, 215-685-6741,, (2) STD Control Program, Philadelphia Department of Public Health, 500 South Broad Street, 2nd Floor, Philadelphia, PA 19146

Background: Chlamydial and Gonorrheal infections constitute a major public health problem in the United States. Philadelphia STD morbidity data suggest that re-infections contribute significantly to the morbidity of chlamydia and gonorrhea in Philadelphia, particularly among young women.

Objectives: To determine the re-infection rates for chlamydia and gonorrhea, as well as describe the deomgraphic and behavioral characteristics of women who become re-infected versus women who are not re-infected.

Methods: Women aged 12-29 years treated for chlamydia, gonorrhea, or both were recruited from an STD clinic and a Family Planning clinic to participate in a ten-minute interview and a follow-up test. Women with a confirmed infection at baseline were re-screened six months after initial treatment.

Results: Of 655 women followed, 63.5% (416/655) were re-tested. Of these women, 26.2% (109/416) were re-infected. Of those re-infected, approximately 70% had chlamydia, 17% had gonorrhea, and 13% had both infections. Univariate analyses show that young age at enrollment and no condom use at last sexual encounter with non-regular partner (p=.025) were associated with re-infection.

Conclusions: Younger women are more likely to be re-infected than are older women. Women who report no condom use at last sexual encounter with sexual partners other than their main partner are more likely to have a subsequent infection.

Learning Objectives:

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

Epidemiology of Non-HIV STDs

The 130th Annual Meeting of APHA